
UpCard-CA1 is a conditionally FDA-approved oral solution containing torsemide at 2 mg/mL (0.2% w/v), supplied in 32 mL and 96 mL bottles for use in dogs and dispensed by Mixlab. Available by prescription.
How to Give Oral Solution
Oral solutions are liquid medications that you give by mouth. In a solution, the medication is completely dissolved in the liquid, so it usually looks clear or evenly colored. Here's how to give it:
Torsemide is a loop diuretic of the pyridyl sulfonylurea class. It acts mainly on the ascending limb of the loop of Henle in the kidney, where it blocks the sodium-potassium-chloride carrier. This reduces sodium and chloride reabsorption and increases urine output.
According to the manufacturer’s labeling, UpCard-CA1 is conditionally approved by FDA pending a full demonstration of effectiveness for the management of pulmonary edema in dogs with congestive heart failure caused by myxomatous mitral valve disease. The labeling describes use alongside pimobendan, spironolactone and an ACE inhibitor.
The actions described here reflect the product’s FDA-approved labeling; your veterinarian determines the appropriate use for your animal. Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing, or monitoring.
The labeling lists kidney failure, severe dehydration, low blood volume, low blood pressure, sensitivity to torsemide and use with other loop diuretics such as furosemide as contraindications. It is intended for stable dogs and is not indicated for dogs in an acute crisis with fluid in the lungs, chest or abdomen. Dogs with a sulfonamide allergy can react to it. Excess diuresis can lead to dehydration, electrolyte changes and collapse, so your veterinarian will check hydration, kidney values and electrolytes before starting, again at 24 and 48 hours and then monthly until your dog is stable. Commonly reported effects include increased urination and thirst, rising kidney values, urinary incontinence, diarrhea, vomiting, reduced appetite and lethargy, and a worsening cough or trouble breathing should be reported right away. NSAIDs can reduce its diuretic response and affect kidney function, and aminoglycoside and cephalosporin antibiotics can add to kidney and hearing risks. Corticosteroids, amphotericin B and digoxin call for electrolyte monitoring, and torsemide can raise the risk of aspirin toxicity. Tell your veterinarian about every medication and supplement your dog receives. It has not been evaluated in dogs with heart disease from other causes or with diabetes, and it has not been evaluated in breeding, pregnant or lactating dogs. Store at or below 86°F and discard 90 days after opening. Not for human use. Keep out of the reach of children and other pets and wash your hands after use or spills. Seek medical advice right away after any accidental ingestion by a person.
Yes. UpCard-CA1 is for prescription use only, so a licensed veterinarian must authorize it.
Conditional approval allows a veterinary drug to be marketed before all effectiveness data are complete, once safety, full manufacturing standards and a reasonable expectation of effectiveness have been shown. The sponsor must complete the remaining data within five years or the approval ends.
Torsemide increases urine output, which can change hydration, kidney values and electrolytes. The labeling calls for monitoring before starting, at 24 and 48 hours and then monthly until your dog is stable.
No. The labeling lists use with other loop diuretics such as furosemide as a contraindication. Ask your veterinarian before changing or adding any diuretic.
Contact Mixlab to discuss your patient’s specific needs — compounding options are evaluated case by case.




